查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2015002

医用视讯内视镜市场：按产品类型、操作模式、应用和最终用户划分－2026-2032年全球市场预测

Medical Videoscopes Market by Product Type, Mode Of Operation, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医用视讯内视镜市场价值将达到 189.9 亿美元，到 2026 年将成长至 204 亿美元，到 2032 年将达到 324.3 亿美元，复合年增长率为 7.94%。

主要市场统计数据
基准年 2025 189.9亿美元
预计年份：2026年 204亿美元
预测年份 2032 324.3亿美元
复合年增长率 (%) 7.94%

本策略性入门指南概述了技术进步、临床期望和营运现实如何相互交织，从而重新定义视讯内视镜在现代医疗保健中的应用。

目前医用视讯内视镜的发展现状是临床需求、技术创新和采购要求之间复杂相互作用的结果，直接影响手术室和专科诊所。光学技术的进步、感测器的小型化以及数位整合技术的提升，提高了临床医生对影像保真度、操作性和一次性工作流程的期望。同时，医院管理者和供应链负责人优先考虑设备的生命週期成本、再处理要求以及与现有影像和记录系统的互通性。

影像技术的快速发展、临床实践向微创医学的转变以及采购优先事项的变化，正在重新定义医疗保健系统中视讯内视镜的应用。

目前，技术、临床和政策因素的整合正在推动变革，促使视讯内视镜的设计、采购和使用方式发生根本性改变。首先，成像感测器、LED照明和紧凑型机壳设计等技术的成熟，催生了新一代设备，这些设备在缩小探头直径的同时，实现了更高的解析度和更优异的弱光性能。这些技术进步直接转化为临床优势，例如在狭窄的解剖结构中实现更清晰的视野、缩短手术时间以及扩大诊断范围。

评估 2025 年关税措施将如何重塑视讯内视镜产业的供应链、采购趋势和筹资策略，以及由此产生的连锁营运影响。

美国将于2025年实施的关税调整将对Videoscope的整个价值链产生一系列累积影响，包括采购选择、定价策略和供应商网路建构。某些医疗设备组件和成品的进口关税上调，将立即给依赖跨境供应链的製造商带来成本压力。因此，企业被迫做出策略决策：自行承担增加的成本、转嫁给买家，或重组供应链网路以降低风险。

从详细的细分观点解释产品设计、操作模式、临床应用和最终用户环境如何全面影响设备选择和采购行为。

细分市场分析揭示了推动整个视讯内视镜市场采用和采购行为的清晰趋势，这些趋势涵盖产品、操作、应用和最终用户。根据产品类型，市场可分为柔性视讯内视镜和刚性视讯内视镜。柔性视讯内视镜又可细分为双通道型（可同时进行器械插入和吸引）和单通道型（针对小直径手术进行了优化）。硬式影像内视镜包括用于关节可视化的关节镜系统、用于腹部手术的腹腔镜器械以及用于精确进入头颈部解剖结构的耳鼻喉科内视镜。这些产品之间的差异也体现在设计重点的不同：软性内视镜优先考虑操作性和通道配置，而刚性系统则优先考虑结构刚性和整合工作通道。

一项全面的区域分析重点阐述了法律规范、采购惯例和临床基础设施的多样性如何导致世界各地出现不同的部署模式。

区域趋势不仅影响需求模式，还影响监管策略、供应商企业发展以及跨洲临床应用轨迹。在美洲，采购惯例往往着重于综合服务合约、完善的上市后监管以及与医院集团采购组织的合作。这些因素有利于那些能够提供可靠的临床证据、快速回应服务网络以及根据医疗机构预算量身定制的灵活定价结构的供应商。

竞争分析表明，光学技术的创新和卓越的服务，再加上供应链的韧性，为市场领导带来了明显的竞争优势。

视讯内视镜产业的竞争动态体现了产品创新、供应链韧性以及支持临床和营运工作流程能力的综合作用。主要企业正致力于提升光学性能、人体工学设计以及整合数位平台，以促进影像撷取、标註以及与电子健康记录的互通性。这些功能提高了临床医生的工作效率，并支持医疗机构在文件记录和品质评估方面实现更广泛的目标。

为製造商和买家提供可操作的、高优先顺序的策略行动，以降低供应风险、增强产品适应性，并使经营模式与临床价值保持一致。

产业领导企业可以采取多项切实可行的措施，将市场洞察转化为强大的竞争优势，同时降低营运和监管风险。首先，应优先考虑模组化产品设计和製造柔软性，使核心光学平台能够快速适应不同的通道配置和区域监管要求。这种方法可以减轻单一产品开发流程的负担，并缩短区域响应型产品的上市时间。

透过结合临床医生的见解、监管审查和供应商的技术检验，我们透明、多方面的研究途径能够产生可追溯的决策见解。

本执行摘要依据的研究整合了第一手和第二手研究资料，包括临床实践文献、监管指南、供应商资讯披露以及结构化专家访谈。第一手资料来源包括与相关专科的临床医生、消毒专家和医院采购经理的讨论，旨在了解实际应用中医疗设备的选择标准和运作限制。这些从业人员的观点与监管文件和供应商技术规范进行了交叉比对，以检验有关医疗设备性能声明的有效性。

最终的综合分析强调了透过平衡技术进步、营运韧性和策略采购来维持临床卓越性的重要性。

总之，内视镜生态系统正处于技术快速发展与操作复杂性交彙的阶段。影像技术和仪器人体工学的进步拓展了临床应用的可能性，而采购现状、消毒要求和不断变化的贸易政策则带来了新的限制因素，相关人员必须积极应对。这些因素的相互作用迫使供应商不仅要在产品功能方面进行创新，还要在服务交付、供应链设计和永续性措施方面进行创新。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 医用视讯内视镜市场：依产品类型划分

  • 软式影像内视镜
    • 双通道
    • 单通道
  • 硬式影像内视镜
    • 关节镜
    • 腹腔镜
    • 耳鼻喉科

第九章 医用视讯内视镜市场：依操作模式划分

  • 一次性的
  • 可重复使用的

第十章：医用视讯内视镜市场：按应用领域划分

  • 耳鼻喉科
  • 胃肠病学
  • 呼吸内科
  • 泌尿系统

第十一章 医用视讯内视镜市场：依最终用户划分

  • 日间手术中心
  • 诊断中心
  • 医院
  • 专科诊所

第十二章 医用视讯内视镜市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 医用视讯内视镜市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 医用视讯内视镜市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国医用视讯内视镜市场

第十六章：中国医用视讯内视镜市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CONMED Corporation
  • FUJIFILM Holdings Corporation
  • HOYA Corporation
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • Stryker Corporation
  • Welch Allyn, Inc.
Product Code: MRR-0363DFE0367A

The Medical Videoscopes Market was valued at USD 18.99 billion in 2025 and is projected to grow to USD 20.40 billion in 2026, with a CAGR of 7.94%, reaching USD 32.43 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 18.99 billion
Estimated Year [2026] USD 20.40 billion
Forecast Year [2032] USD 32.43 billion
CAGR (%) 7.94%

A strategic primer outlining how technological advancement, clinical expectations, and operational realities converge to redefine videoscope utilization in modern care settings

The medical videoscope landscape intersects clinical demand, engineering innovation, and procurement imperatives in ways that directly influence operating suites and specialty clinics. Advances in optics, sensor miniaturization, and digital integration have elevated clinician expectations for image fidelity, maneuverability, and single-use workflows. Meanwhile, hospital administrators and supply chain officers prioritize device lifecycle costs, reprocessing requirements, and interoperability with existing imaging and documentation systems.

As a result, devices originally conceived as niche diagnostic tools now serve as central components of procedural pathways across multiple specialties. This repositioning drives cross-functional decision-making where surgeons, endoscopy nurses, sterile processing teams, and purchasing departments must align on capital planning, device selection, and staff training. Moreover, regulatory scrutiny of reprocessing protocols and infection control further shapes procurement criteria.

Consequently, understanding the interplay between clinical outcomes and operational constraints becomes essential for vendors and health system leaders. This introduction sets the stage for a deeper exploration of transformational shifts, tariff-related pressures, segmentation nuances, regional dynamics, competitive positioning, and actionable recommendations that follow.

How rapid advancements in imaging technology, shifting clinical practice toward minimally invasive care, and evolving procurement priorities are redefining videoscope deployment across healthcare systems

The current landscape is experiencing transformative shifts driven by converging technological, clinical, and policy forces that are reshaping how videoscopes are designed, procured, and utilized. First, technological maturation in imaging sensors, LED illumination, and compact form factors has enabled a new generation of devices that offer higher resolution and improved low-light performance while reducing probe diameter. These engineering advances translate directly into clinical benefits such as improved visualization in narrow anatomy, reduced procedure time, and expanded diagnostic reach.

In parallel, clinical practice patterns are shifting toward minimally invasive procedures and outpatient care pathways, prompting demand for devices that deliver consistent performance in ambulatory surgery centers as well as hospital operating rooms. Additionally, infection prevention priorities and the practicalities of sterile processing have accelerated interest in single-use and hybrid device strategies. This trend affects not only purchasing cycles but also capital budgeting and staff competency requirements.

At the policy level, evolving reimbursement frameworks and procurement guidelines are increasingly emphasizing value-based outcomes, which heighten scrutiny on total cost of care rather than upfront device price alone. Collectively, these shifts compel manufacturers to innovate not only in product features but also in service models, warranty offerings, and lifecycle support. Consequently, stakeholders must reassess supplier partnerships, clinical training programs, and inventory strategies to remain aligned with these transformative currents.

Assessment of how 2025 tariff measures have reshaped supply chains, procurement dynamics, and sourcing strategies across the videoscope industry with cascading operational implications

Tariff adjustments introduced in the United States in 2025 exert a series of cumulative effects across the videoscope value chain, influencing sourcing choices, pricing strategies, and supplier network architecture. Increased import duties on specific medical device components or finished products create immediate cost pressure for manufacturers that rely on cross-border supply chains. As a result, firms face strategic decisions about whether to absorb cost increases, pass them through to buyers, or reconfigure supply networks to mitigate exposure.

In response, many global suppliers accelerate nearshoring, diversify contract manufacturing, or shift component sourcing toward economies with preferential trade arrangements. These adaptations reduce single-source risk but also introduce transition costs such as qualification testing, tooling investment, and regulatory submissions for products manufactured in new facilities. Consequently, lead times may lengthen initially while companies stabilize alternative suppliers and validate production quality.

Procurement teams and clinical leaders experience secondary impacts as hospitals and surgical centers reassess procurement cycles and budgets. Contract renegotiations become more frequent as buyers seek price protection clauses, currency adjustment mechanisms, or supplier commitments on cost containment. Meanwhile, reimbursement and purchasing committees place greater emphasis on product total-cost-of-ownership analyses that account for potential tariff-driven volatility.

Finally, regulatory and compliance teams contend with documentation updates and potential changes to component provenance declarations. In sum, the cumulative impact of tariff measures in 2025 catalyzes a strategic reorientation across the ecosystem: suppliers redesign supply chains for resilience, buyers tighten contractual safeguards, and clinical stakeholders collaborate more closely with procurement to ensure continuity of care with minimal disruption.

In-depth segmentation perspective explaining how product design, operational mode, clinical application, and end-user settings collectively influence device selection and procurement behavior

Segmentation analysis reveals distinct product, operation, application, and end-user dynamics that drive adoption and procurement behavior across the videoscope space. Based on product type, the market divides between flexible and rigid videoscopes; flexible models split further into dual-channel instruments that support simultaneous instrument passage and suction, and single-channel variants optimized for smaller-diameter navigation. Rigid videoscopes encompass arthroscopy systems for joint visualization, laparoscopy instruments tailored to abdominal procedures, and otolaryngology scopes designed for precise access to head and neck anatomy. These product distinctions translate into divergent design priorities: maneuverability and channel configuration for flexible scopes, and structural rigidity and integrated working channels for rigid systems.

Based on mode of operation, devices are categorized as disposable or reusable, a segmentation that directly affects sterile processing workflows, inventory turnover, and environmental considerations. Disposable devices can simplify logistics and reduce reprocessing risk, while reusable systems often require investments in cleaning, inspection, and repair programs. The operational choice between single-use and reprocessable instruments therefore influences procurement cycles, training requirements, and lifecycle cost conversations.

Based on application, clinical domains such as ENT, gastroenterology, pulmonology, and urology each impose unique performance criteria. ENT procedures demand fine optics and slender profiles for narrow anatomy; gastroenterology emphasizes longer insertion lengths and advanced imaging modes for mucosal assessment; pulmonology requires flexible navigation to distal airways alongside robust suction and sampling capabilities; and urology privileges endoluminal access and compatibility with adjunctive instruments. These application-specific needs drive both feature development and tailored service offerings.

Based on end user, ambulatory surgery centers, diagnostic centers, hospitals, and specialty clinics present varying purchasing frameworks and operational constraints. Ambulatory surgery centers typically favor devices that support fast turnover and predictable costs, diagnostic centers focus on throughput and image quality for high-volume procedures, hospitals balance capital equipment stewardship with multi-specialty use, and specialty clinics prioritize devices that align with focused clinical protocols. Together, these segmentation lenses inform product roadmaps, go-to-market strategies, and the design of training and after-sales support.

Comprehensive regional analysis highlighting how variable regulatory frameworks, procurement practices, and clinical infrastructures drive differentiated adoption patterns across global territories

Regional dynamics shape not only demand patterns but also regulatory strategy, supplier footprints, and clinical adoption curves across the continents. In the Americas, procurement practices often emphasize integrated service contracts, strong post-market surveillance, and alignment with hospital group purchasing organizations. These factors favor suppliers that can demonstrate robust clinical evidence, responsive service networks, and flexible pricing structures aligned to institutional budgets.

Across Europe, the Middle East & Africa, regulatory harmonization initiatives and diverse payer models create a complex adoption ecosystem. In some jurisdictions, centralized procurement and stringent device evaluation frameworks accelerate the uptake of devices that clearly demonstrate improved clinical outcomes and cost-effective sterilization pathways. Elsewhere, fragmented purchasing and variable reimbursement models require suppliers to deploy localized commercial strategies and targeted educational outreach.

In the Asia-Pacific region, rapid expansion of ambulatory care facilities, investments in minimally invasive surgery training, and rising domestic manufacturing capabilities alter competitive dynamics. Local regulatory pathways and government procurement priorities can advantage regional manufacturers, while international suppliers adapt through partnerships, local manufacturing, or tailored product portfolios. Across all regions, infrastructure maturity, clinical training availability, and supply chain resilience remain critical determinants of adoption velocity and device lifecycle management.

Analysis of competitive strengths showing how innovation in optics and service excellence combine with supply chain resilience to create demonstrable advantages for market leaders

Competitive dynamics in the videoscope sector reflect a combination of product innovation, supply chain resilience, and the ability to support clinical and operational workflows. Leading companies invest in optical performance, ergonomic design, and integrated digital platforms that facilitate image capture, annotation, and interoperability with electronic health records. These capabilities enhance clinician efficiency and support broader institutional objectives for documentation and quality measurement.

Manufacturers that pair compelling hardware with robust service models-such as rapid parts replacement, remote diagnostics, and training programs-tend to capture stronger loyalty among hospital systems. Strategic partnerships with contract manufacturers and localized assembly facilities also enable quicker response to shifts in demand and regulatory requirements. In addition, companies that proactively address single-use device sustainability concerns by offering recycling programs or lifecycle assessments gain traction among environmentally conscious purchasers.

Moreover, firms that demonstrate transparent supply chain practices and proactive tariff mitigation strategies are better positioned during periods of policy-induced volatility. Investors and strategic buyers seek companies with diversified revenue streams, established clinical validation, and clear roadmaps for addressing emerging infection control and data integration requirements. Overall, competitive advantage accrues to organizations that harmonize product excellence with operational support and supply chain foresight.

Practical, high-priority strategic actions for manufacturers and purchasers that reduce supply risk, enhance product adaptability, and align commercial models with clinical value

Industry leaders can take several actionable steps to convert market insights into durable advantage while mitigating operational and regulatory risks. First, prioritize modular product design and manufacturing flexibility so that core optical platforms can be quickly adapted to different channel configurations or regional regulatory requirements. This approach reduces the burden of separate product development streams and accelerates time-to-market for localized variants.

Second, develop a diversified supplier base and qualify alternate contract manufacturers proactively to reduce exposure to tariff shocks and logistics disruptions. Complement that strategy with clear provenance documentation and serial-tracking capabilities to facilitate regulatory compliance and recall readiness. Third, strengthen commercial value propositions by bundling devices with training, service guarantees, and data integration tools that help procurement committees evaluate total cost and clinical benefit more holistically.

Fourth, establish sustainability initiatives that address single-use device waste through take-back programs, recyclable materials, or validated reprocessing partnerships where clinically appropriate. Fifth, engage in proactive dialogue with payers and hospital administration to align device evaluation with outcome measures that matter for reimbursement and purchasing decisions. By implementing these steps in concert, companies can enhance resilience, deepen clinical partnerships, and create more defensible positions in competitive tenders.

Transparent multi-method research approach combining clinician insights, regulatory review, and supplier technical validation to produce decision-ready findings with traceable provenance

The research synthesis underlying this executive summary integrates primary and secondary evidence, combining clinical practice literature, regulatory guidance, supplier disclosures, and structured expert interviews. Primary inputs included discussions with practicing clinicians across relevant specialties, sterile processing experts, and hospital procurement leaders to capture real-world device selection criteria and operational constraints. These practitioner perspectives were cross-referenced with regulatory documentation and supplier technical specifications to validate device capability claims.

Secondary sources comprised peer-reviewed clinical studies, guidance documents from regulatory authorities, and public filings that shed light on device performance, safety considerations, and post-market surveillance outcomes. Analytical steps included triangulating qualitative insights with supplier declarations to identify recurring themes around durability, ergonomics, and sterilization compatibility. The methodology also incorporated scenario analysis to explore supply chain responses to policy changes and to surface pragmatic mitigation strategies for stakeholders.

Throughout, the approach emphasized transparency and traceability: sources were evaluated for recency and relevance, and divergent perspectives were highlighted to ensure balanced conclusions. This multi-method approach supports robust, decision-ready insights while acknowledging areas where further empirical research or targeted field validation would strengthen specific findings.

Final synthesis emphasizing the imperative to balance technological advancement with operational resilience and strategic procurement to sustain clinical excellence

In conclusion, the videoscope ecosystem stands at a nexus of rapid technological progress and operational complexity. Advances in imaging and device ergonomics are expanding clinical possibilities, while procurement realities, sterilization imperatives, and evolving trade policies impose new constraints that stakeholders must actively manage. The interplay of these forces encourages suppliers to innovate not only in product features but also in service delivery, supply chain design, and sustainability initiatives.

For clinical leaders and procurement officers, the challenge is to align device selection with broader institutional objectives-balancing clinical efficacy, operational efficiency, and fiscal prudence. For manufacturers, the imperative is to deliver adaptable platforms, transparent supply practices, and compelling post-sale support that demonstrably reduce total cost and clinical risk. Ultimately, organizations that integrate technological excellence with resilient operational strategies will be best positioned to meet clinician needs and support high-quality patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Videoscopes Market, by Product Type

  • 8.1. Flexible Videoscopes
    • 8.1.1. Dual Channel
    • 8.1.2. Single Channel
  • 8.2. Rigid Videoscopes
    • 8.2.1. Arthroscopy
    • 8.2.2. Laparoscopy
    • 8.2.3. Otolaryngology

9. Medical Videoscopes Market, by Mode Of Operation

  • 9.1. Disposable
  • 9.2. Reusable

10. Medical Videoscopes Market, by Application

  • 10.1. ENT
  • 10.2. Gastroenterology
  • 10.3. Pulmonology
  • 10.4. Urology

11. Medical Videoscopes Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Specialty Clinics

12. Medical Videoscopes Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Videoscopes Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Videoscopes Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Videoscopes Market

16. China Medical Videoscopes Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Boston Scientific Corporation
  • 17.7. CONMED Corporation
  • 17.8. FUJIFILM Holdings Corporation
  • 17.9. HOYA Corporation
  • 17.10. KARL STORZ SE & Co. KG
  • 17.11. Medtronic plc
  • 17.12. Olympus Corporation
  • 17.13. Richard Wolf GmbH
  • 17.14. Smith & Nephew plc
  • 17.15. Stryker Corporation
  • 17.16. Welch Allyn, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL VIDEOSCOPES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL VIDEOSCOPES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DUAL CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DUAL CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DUAL CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SINGLE CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SINGLE CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SINGLE CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ARTHROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY OTOLARYNGOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY OTOLARYNGOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY OTOLARYNGOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY ENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY PULMONOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY PULMONOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 127. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 128. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 129. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. GCC MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 148. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 149. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 150. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. G7 MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 155. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 156. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 157. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. NATO MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL VIDEOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY FLEXIBLE VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY RIGID VIDEOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY MODE OF OPERATION, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA MEDICAL VIDEOSCOPES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)